BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9314640)

  • 1. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
    Ceriello A; Bortolotti N; Pirisi M; Crescentini A; Tonutti L; Motz E; Russo A; Giacomello R; Stel G; Taboga C
    Diabetes Care; 1997 Oct; 20(10):1589-93. PubMed ID: 9314640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total radical-trapping antioxidant parameter in NIDDM patients.
    Ceriello A; Bortolotti N; Falleti E; Taboga C; Tonutti L; Crescentini A; Motz E; Lizzio S; Russo A; Bartoli E
    Diabetes Care; 1997 Feb; 20(2):194-7. PubMed ID: 9118773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects.
    Ceriello A; Bortolotti N; Crescentini A; Motz E; Lizzio S; Russo A; Ezsol Z; Tonutti L; Taboga C
    Eur J Clin Invest; 1998 Apr; 28(4):329-33. PubMed ID: 9615913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM.
    Leinonen J; Rantalaiho V; Lehtimäki T; Koivula T; Wirta O; Pasternack A; Alho H
    Free Radic Res; 1998 Oct; 29(4):273-81. PubMed ID: 9860042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meal-generated oxidative stress in type 2 diabetic patients.
    Ceriello A; Bortolotti N; Motz E; Crescentini A; Lizzio S; Russo A; Tonutti L; Taboga C
    Diabetes Care; 1998 Sep; 21(9):1529-33. PubMed ID: 9727904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients.
    Fernández-Castañer M; Camps I; Fernández-Real JM; Domenech P; Martínez-Brotons F
    Acta Diabetol; 1996 Jul; 33(2):118-21. PubMed ID: 8870813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C activation in NIDDM patients.
    Gabazza EC; Takeya H; Deguchi H; Sumida Y; Taguchi O; Murata K; Nakatani K; Yano Y; Mohri M; Sata M; Shima T; Nishioka J; Suzuki K
    Diabetologia; 1996 Dec; 39(12):1455-61. PubMed ID: 8960826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
    Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
    Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus.
    Maxwell SR; Thomason H; Sandler D; Leguen C; Baxter MA; Thorpe GH; Jones AF; Barnett AH
    Eur J Clin Invest; 1997 Jun; 27(6):484-90. PubMed ID: 9229228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidants in the serum of children with insulin-dependent diabetes mellitus.
    Asayama K; Uchida N; Nakane T; Hayashibe H; Dobashi K; Amemiya S; Kato K; Nakazawa S
    Free Radic Biol Med; 1993 Dec; 15(6):597-602. PubMed ID: 8138185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.
    Lönnrot K; Metsä-Ketelä T; Molnár G; Ahonen JP; Latvala M; Peltola J; Pietilä T; Alho H
    Free Radic Biol Med; 1996; 21(2):211-7. PubMed ID: 8818636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes.
    Ceriello A; Bortolotti N; Motz E; Lizzio S; Catone B; Assaloni R; Tonutti L; Taboga C
    Eur J Clin Invest; 2001 Apr; 31(4):322-8. PubMed ID: 11298779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of prothrombin fragment 1 + 2 and fibrin dimer in the detection of hypercoagulation in obstetrical patients with thrombosis risk factors].
    Romero-García F; Angulo-Vázquez J; Hernández-Montiel JL; Luna-Zaizar H; de la Torre-Torres S
    Ginecol Obstet Mex; 1998 Nov; 66():456-61. PubMed ID: 9823703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total free radical trapping antioxidant potential in pre-eclampsia.
    Kharb S
    Int J Gynaecol Obstet; 2000 Apr; 69(1):23-6. PubMed ID: 10760528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
    Clermont G; Lecour S; Lahet J; Siohan P; Vergely C; Chevet D; Rifle G; Rochette L
    Cardiovasc Res; 2000 Aug; 47(3):618-23. PubMed ID: 10963735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
    MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant status of neonates exposed in utero to tobacco smoke.
    Fayol L; Gulian JM; Dalmasso C; Calaf R; Simeoni U; Millet V
    Biol Neonate; 2005; 87(2):121-6. PubMed ID: 15539769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
    Praticò D; Ferro D; Iuliano L; Rokach J; Conti F; Valesini G; FitzGerald GA; Violi F
    Blood; 1999 May; 93(10):3401-7. PubMed ID: 10233892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
    Langley SC; Brown RK; Kelly FJ
    Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.